SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection

Given high SARS-CoV-2 incidence, coupled with slow and inequitable vaccine roll-out in many settings, there is a need for evidence to underpin optimum vaccine deployment, aiming to maximise global population immunity. We evaluate whether a single vaccination in individuals who have already been infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jia, Matthews, Philippa C., Stoesser, Nicole, Diamond, Ian, Studley, Ruth, Rourke, Emma, Cook, Duncan, Bell, John I., Newton, John N., Farrar, Jeremy, Howarth, Alison, Marsden, Brian D., Hoosdally, Sarah, Jones, E. Yvonne, Stuart, David I., Crook, Derrick W., Peto, Tim E. A., Walker, A. Sarah, Eyre, David W., Pouwels, Koen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243074/
https://www.ncbi.nlm.nih.gov/pubmed/35768431
http://dx.doi.org/10.1038/s41467-022-31495-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243074/
https://www.ncbi.nlm.nih.gov/pubmed/35768431
http://dx.doi.org/10.1038/s41467-022-31495-x

Ejemplares similares